Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Premarket BID 274600/ASK 407600 @ 75CAD, 09:13 est
Martello Acquires Savision B.V. to Accelerate Growth
https://www.newswire.ca/news-releases/martello-acquires-savision-bv-to-accelerate-growth-697564121.html
Extends network and IT performance management capabilities and expands sales presence in key European markets.
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES./
OTTAWA, Oct. 15, 2018 /CNW/ - ("Martello" or "the Company") (TSXV: MTLO), a leading provider of network performance management solutions for real-time communications, announced today that it has signed a share purchase agreement to acquire ("Savision"), subject to final approval of the transaction by the TSX Venture Exchange ("TSXV") and the completion of the standard conditions to closing for this type of transaction. More than 5,000 businesses and government organizations are already under management with Martello's solutions, in 150 countries around the world. Savision was founded in 2006 and provides enterprise software for the visualization of IT systems management data such as performance metrics, outage information and incidents. Deployed in over 50 countries around the world, Savision's software is an ITOps solution that integrates and controls monitoring, cloud, and service management tools data in a single pane of glass.
Under the terms of the share purchase agreement, Martello will purchase, through its wholly owned subsidiary, Martello Technologies Corporation, all issued and outstanding shares of Savision for an aggregate purchase price of $11,966,504, subject to adjustment, payable as follows: (i) a cash payment of $3,734,504 and (ii) the issuance of 18,709,090 shares in the Company's share capital to the shareholders of Savision at a price of $.44 per share. A finder's fee of $358,625 is payable to Sampford Advisors, who acted as exclusive M&A adviser to Martello on this transaction.
Transaction Highlights:
Martello's Recurring Revenue is Accelerated
Savision's recurring subscription-based software has more than 900 customers, with 2017 revenues of over $4.5 million (CDN). Prior to this transaction, approximately 60% of Martello's total revenues were from subscription-based sales of software products, and this will be accelerated with the acquisition of Savision. More than 50 new partners will be added to Martello's channel sales program. Headquartered in Amsterdam, Savision has 32 employees.
Savision CEO Stefanie Richheimer Joins Martello as Chief Revenue Officer
Stefanie Richheimer, CEO of Savision, will join Martello as Chief Revenue Officer, effective upon final TSXV approval of the transaction. Ms. Richheimer is a seasoned industry expert in Software, IT & Retail. She was the Managing Director for a market-leading consumer retail chain with 35 outlets before successfully leading her own start-up to become one of the key IT firms in The Benelux. Following that, Ms. Richheimer was an integral part of the Federal government's Direct Foreign Investment team for the City of Amsterdam. She is also co-founder of AmsterdamPark Capital, an early-stage technology investor.
Martello's Sales Team will Double in Size with an Expanded Global Presence
Led by Chief Revenue Officer Stefanie Richheimer, the size of Martello's sales and marketing team will double with this acquisition, accelerating the ability to cross-sell the Company's suite of network and IT performance management capabilities to its growing base of channel partners and MSPs. The Company will have sales personnel in Canada, the US and Europe.
The Company will Pursue Joint Opportunities in Network and IT Performance Management
Martello will team its suite of network and IT performance management capabilities, developed over more than 8 years, to address joint opportunities to solve its customers' problems.
"I'm delighted to welcome Stefanie and the entire Savision team to the Martello family", said John Proctor, President and CEO of Martello. "We expect this acquisition to be accretive to Martello, as we expand our network and IT performance management capabilities and leverage a talented, globally distributed team with a track record of success".
"Together, we will build a global network and IT performance management leader", said Stefanie Richheimer, CEO of Savision. "Our expanded global sales force will cross-sell a solid portfolio of network and IT performance management products. I look forward to working with John and the Martello team to drive sales of this growing suite of solutions".
Martello has a positive track record in merger and acquisition activity, having acquired Netvitesse in 2014, and Elfiq Networks in December 2017. The Company's solutions have been recognized by the industry. In September, Martello received a Frost & Sullivan Leadership Award for NPM (Network Performance Management) and ranked as Ottawa's Fastest Growing Company, at No. 28 on the Growth 500 list of Canada's Fastest Growing Companies. The Company recently went public with a TSXV listing, following the closure of an oversubscribed $7.5 million private placement.
9
The older weed gets, the better it is. True or false?
It’s not wine. Once cannabis has been cured, there’s no improvement to be made over time. That being said, if you store it properly, it’ll last for a long time and not lose quality. So that’s a good thing.
https://tweed.com/en/vault/articles/top-9-myths-and-misconceptions-about-cannabis--plus-1-bonus-beca
I’m considering it more as an ‘End of Prohibition” purchase than a Cannabis Conservation effort.
Conversation peace with the Grandchildren when I’m a centurion maybe.
OPINION
The cannabis fight is far from over
ALAN YOUNG
THE GLOBE AND MAIL
October 12 at 12:39 MT
Legalization is only the start: Canada must do right by its 'cannabis criminals’
https://www.theglobeandmail.com/opinion/article-the-cannabis-fight-is-far-from-over/
Wo: I am an avid reader, and this activity just so happens to go very well with Cannabis and Investing. The article included above, although lengthy in comparison, and to the chagrin of some on this board, is one I consider to be worthy of the time well wasted reading it, as to the time writing and also fulfilling the ideas therein.
Cheers
Q&A: Bruce Linton of Canopy Growth on being a nerd and cannabis ‘spokesman’
?THE GLOBE AND MAIL
https://www.theglobeandmail.com/business/article-qa-bruce-linton-of-canopy-growth-on-being-a-nerd-and-cannabis/
?October 12 at 12:40 MT?Cannabis legalization has been a long time coming, but Bruce Linton is looking much further into the future than that.?The founder and co-chief executive officer of Canopy Growth Corp., based in Smiths Falls, Ont., imagines a day when cannabis-infused drinks are on shelves next to the vodka. “The next wave of products are going to be massively more interesting and popular than the first ones,” he says about Canada’s cannabis market.?Now, a few days before the Oct. 17 legalization of recreational cannabis, Mr. Linton talks about hanging out with Snoop Dogg, teaching his sons about his company’s product and sparking innovation over the next year or two.
Mr. Linton was interviewed for I’ll Go First, a new podcast series about entrepreneurs produced by The Globe and Mail.?So let’s get this out of the way first: Have you ever smoked cannabis?
Yes, I have. It was when I was in university. I think, like many people, I’m not necessarily a fan of combusting things and inhaling the result. Rather than understanding what I was getting into, I jumped right in the deep end with people who consumed a lot of cannabis. The effect was that I became the entertainment for the next hour or two because I was disproportionately stoned compared to them. I give you that detail because I think a big part of the cohort who are going to be interested in cannabis in Canada may or may not have used it before, and they likely would prefer to get it from a stabilized, responsible supplier. We’ll call it a “moderate on-ramp” for them. You don’t want to try and pretend you’re Snoop Dogg because I believe, having hung out with Snoop now several times, he would have been just fine with the product that I used the first time, and I was not.? How often do you see Snoop Dogg??He came out to Smiths Falls, Ont., recently. Smiths Falls is essentially three hours east of Toronto, one hour southwest of Ottawa, three hours west of Montreal, so in the middle of nowhere. Each year in order to appreciate the community, we put on a show on our front lawn. If you live outside the community you need to pay 20 bucks and we take all that money and dedicate it to creating a better community. The opening act is my two boys and their band, they’re the ripe old age of 15 and 17 now. Anyway, this year Snoop Dogg did a whole one-hour-plus set, and it was amazing. It was also amazing because this was in that town I described, which had also been really quite downtrodden by Hershey departing, as well as most of the other employers. So the town hadn’t had many really great things happen the last 15 years until a marijuana company occupied the biggest building and then ultimately brought Snoop to have a party on a front lawn and do a great set on a Saturday night.
Tell me a little bit about being a father.
There are some advantages and disadvantages of having me for a dad. The disadvantage list is reasonably long – I work fairly hard, I’m very busy and I can’t always make it to everything. The advantages list includes getting to open for the shindig each year.?How do you talk to them about cannabis??We have a visitor centre now at the Smiths Falls facility, and people, including their children, can learn about the history of cannabis, the science of cannabis, and see cannabis plants in various states. And I refer to that as sort of like swimming lessons for cannabis. And my kids have had a lot of swimming lessons for cannabis because they understand a lot about it. Which means they’re unlikely to come to harm related to cannabis because they comprehend why you’d have to be completely out of your noggin to just buy a bag from somebody you don’t know.?My kids have been coming to the facility from the day I began building the thing, and they understand it. They’re proud to wear the shirts, they explain to people the difference between medical use and otherwise.
How do you navigate being an innovator in this new industry? ?You need to be a nerd; that’s very helpful. I like technology, I like public policy. If you’re going to create something that is going to be heavily regulated, you have to rely on technology in order to make it scale. You have to be of the view that rules are made to be followed and evolve but not broken.?The reason I stepped into this sector is because of a newspaper. If you think about it, there are probably 100 good businesses presented in the newspaper every day. And the one that I saw was back in 2012; Stephen Harper was our prime minister, and the police chiefs of Canada were not happy with the laws regarding marijuana because it was not evident who was a criminal and who was not. My theory was that Mr. Harper would be very unlikely to get re-elected if he didn’t have the support of the people who like the police, so he would fix it.?And with that I started digging around to find out what the public policy was and might be.?Do you find that you have to be a spokesman for cannabis? ?This sector does need a spokesperson, and the person has to welcome the duty of explaining it. For example, probably 500 times people have said, “Well, there’s no clinical trial data.” There is some, but honestly do you believe the illicit market is in the business of running clinical trials for something that’s illegal? It’s a nonsensical statement. But you can’t get frustrated at that, you simply have to explain.?What happens if there’s a drop in interest, or people don’t purchase as much cannabis as predicted??I think the first wave of products are going to be purchased because it’s novel. But there is an obligation of Health Canada to introduce new and more advanced formats or products in the second half of 2019. Not so that you can have a better time or I can run a better business, but so that we can compete more effectively with the illicit market. And so that’s when you’ll see things like vape pens, but more importantly you’ll see things that I would call ingestibles, not edibles. Ingestible means you could drink or chew it. And if we then can make beverages with Constellation Brands [the global alcohol company announced in August that it would make a $5-billion investment in Canopy], items that are clear, that have no calories and trigger a much more positive, uplifting feeling than happens with alcohol, I think that the next wave of products are going to be massively more interesting and popular than the first ones. The “stretching exercise” of the first nine months will have been helpful but not really indicative of what’s going to occur over the duration of the opportunity.
Tell me about your perfect day off.?No cell coverage.?What’s one word that your friends would use to describe you? ?Intense.?Favourite Snoop Dog song? ?Drop It Like It’s Hot.?How many hours on average do you sleep per night??Four and a half. I sleep like a rock. I wake up going, “That was awesome.” Except it’s not awesome because it’s two-thirty in the morning. So I get up and patrol our house. I make sure there’s nothing going on in the neighbourhood.?What piece of advice would you tell your younger self??I think if it were easy everybody would do it. I have never figured out an easy and direct path to anything. And my mother has pointed that out to me for about 30 years. But it still frustrated me ridiculously early on – that exactly what I thought should happen didn’t happen when I tried it.?If you could do it all over again – creating Canopy – what would you do differently? ?I would probably be a bit more cautious at the beginning. It was such an unusual response I got from everybody that I presented this to. The first three or four people I asked – what do you think of this idea, do you want to start it with me? – they thought I’d lost my marbles. And so then you start wondering: Is this actually a good idea? And so I onboarded a few people early on just because they were willing to do it rather than my usual way, which is I’m pretty demanding.?The Globe and Mail
Access to medical cannabis regulation will remain in place at least five more years: Health Canada
https://www.theglobeandmail.com/cannabis/article-access-to-medical-cannabis-regulation-will-remain-in-place-at-least/
Published 10 hours ago
With so much attention on Oct. 17, the day recreational cannabis will become legal in Canada, it has been largely overlooked that a separate, decades-old system will continue to operate for users of medical cannabis.
This is not without controversy, but Health Canada has wisely decided that the Access to Cannabis for Medical Purposes Regulations (ACMPR) will remain in place for at least five more years to allow medical cannabis to find its place in this brave new world of weed.
There are currently 330,000 registered users of medical cannabis across Canada. That number will no doubt fall in the coming months as access without a prescription becomes easier. Yet the number of actual users of medical cannabis is expected to rise sharply in the coming years.
Story continues below advertisement
To understand that paradox, a little background is required.
Under the current ACMPR system, patients get prescriptions from physicians and purchase their drugs – dried cannabis, oils or seeds to grow their own – from 120 licensed producers.
But it’s not clear how many of those registered users are actually using cannabis to treat a medical condition.
Some people with prescriptions were seeking a legal way of purchasing the recreational product and will now be able to get it more readily online or at retail outlets.
For some patients, too, it will be easier to buy medicinal products without a prescription.
Furthermore, it is an open secret that there is a certain amount of diversion taking place under the current rules. Some prescription mills have “patients” who have been prescribed massive quantities of cannabis and who often assign the right to grow their own to a third party – product that ends up on the shelves in dispensaries, which are still illegal.
Yet there are good reasons for legitimate patients suffering from everything from arthritis to shingles pain to continue using the current ACMPR system.
Story continues below advertisement
When drugs are prescribed, the costs are sometimes reimbursed by private insurers and can be claimed as medical expenses for income-tax purposes. In many jurisdictions, medical cannabis is not taxed; in Canada, patients will pay the same excise tax as recreational users – about $1 a gram – and that’s a sore point.
Cannabis has been used medicinally for almost 5,000 years – in Canada, right up to prohibition in 1923.
It re-entered the mainstream a couple of decades ago after legal challenges from patients using the product illegally.
In July, 2000, the Ontario Court of Appeal threw out charges of possession and cultivation against Terry Parker, a man who had used cannabis for many years to control his severe epilepsy. The court said denying patients access to medical marijuana violated their constitutional rights.
In response, the federal government created the Medical Marijuana Access Program. It was beset with problems and legal challenges that, with no small amount of growing pains, led to the current ACMPR system.
The approach works fairly well – except that, other than a handful of specialized clinics, only about 10 per cent of physicians are willing to prescribe cannabis.
Story continues below advertisement
The Canadian Medical Association has never been enthused about medical cannabis and has asked for the current regime to be dismantled, arguing that medical cannabis lacks good evidence.
It is true that evidence is lacking, but research has been stymied by criminalization. Legalization should, among other things, allow more and better research.
While anecdote is not evidence, we should not dismiss the well-documented experiences of patients with medical cannabis (supplanted by some research), especially in treating chronic pain, nausea during cancer treatment, some forms of epilepsy and post-traumatic stress disorder.
Of course, that doesn’t mean medical cannabis is a miracle cure-all. Like every drug, it has some potential benefits and harms.
The reality is that many patients, young and old, are using medical cannabis. As the stigma falls and the evidence grows, many more will be joining their ranks.
They shouldn’t be getting advice from budkeepers and cannabis sommeliers.
The current system isn’t perfect, but it’s worth maintaining because it provides a clear delineation between recreational and medicinal users. Patients want the relief cannabis can sometimes provide, but they desperately need medical oversight from physicians and pharmacists, particularly when they are using other prescription drugs, as interactions can be dangerous.
They also need better formulations – not just weed to smoke, but oils, sprays, drops, suppositories and pills with proper indications and clear dosages.
Canada is already, in many ways, a leader in the field of medical cannabis. In the coming years, it needs to grow up a little bit, with well-trained physicians prescribing, well-versed pharmacists dispensing and well-informed patients using cannabis products appropriately and responsibly.
WEED DID IT.
https://weeddidit.splashthat.com
A 10/17 CELEBRATION.
WHERE
THE DRAKE HOTEL
1150 QUEEN STREET WEST
TORONTO ON
WHEN
OCTOBER 17 2018 6:00PM
RSVP
19+. MUST BRING VALID ID.
https://weeddidit.splashthat.com
Speculation: Come Oct 31, after the closing of the STZ investment deal, Canopy will have 1/3 of its Market Cap is CASH. Another ~ 1.5 billion in tangible assets, another ~ 1.5 Billion in intangible assets. Roughly 2 weeks post prohibition in Canada, sales growth will perhaps be on its way for triple digit growth q over q. Meanwhile UK and Germany are on pace to mirror Canada’s development, and Look who’s perking up their ears to the south. November has always been a wild month. IMO
There are only 10 Tweed Brands on display on Tweed.com? I’m really curious as to what will be on sale in the stores and online. Will the craft growers, LBS, DNA be on sale? OCS hasn’t launched their web page as yet. Reports are saying 70 strains will be available. I’m considering making a connoisseur/ collection purchase. Something not to be opened for many years.
Leafs By Snoop: Palm Tree CBD, for an appetizer.
Hi Folks, Look here! nice to see some very familiar 'faces' here. This is a beautiful thing. Isn't it? What and Co incidence? Anywhoo, Ive expressed interest in the IPO for Alta Gas Canada and Im here to participate in any discussions in this regard. Through the prospectus, I've read a 1:1 total Asset to Liabilities, which to me infers this companies ipo is in a consolidation period. I really like the 25 and 60 year delivery agreements tied to BCPI and the roughly 8% revenue growth annually over the past 5 years. The Dividend proposal is also very attractive. So here goes. Glad to be of acquaintance to the board, and hopefully my expression of interest is fulfilled. Cheers.
For you, Oct. 17 is just another day
https://spectrumcannabis.com/canada/en/news/For-you-Oct-17-is-just-another-day?utm_source=Spectrum+Cannabis+Patients&utm_campaign=5d0d6e229d-EMAIL_CAMPAIGN_2018_08_23_07_06_COPY_01&utm_medium=email&utm_term=0_b9e84e61ff-5d0d6e229d-146871969&mc_cid=5d0d6e229d&mc_eid=f43ab550f1
October 11, 2018 • Spectrum Cannabis Share
For medical cannabis customers like you, October 17 (the date that recreational cannabis becomes legal) won’t significantly change the way you order and receive the Spectrum Cannabis products you have come to rely on. To address any questions you have about how the legalization of recreational cannabis affects you and to better meet your needs, we are extending the hours of Customer Care for medical patients from 6 am to 10 pm EST, 7 days a week.
We will continue to keep our promises simple
It will also be business as usual for us after October 17 as we continue to prioritize our medical patients. This means unique pricing for medical customers:
New pricing on 15-gram jars of dried flower products, which will result in a $5 savings
All Spectrum Cannabis dried flower products priced at no more than $8.50/gram
We cover the government’s excise tax on Spectrum Cannabis products, which will be applied to cannabis products effective October 17
Compassionate Pricing for qualifying medical customers
Ensuring the supply of high-quality medical cannabis for medical customers
You can be confident about the quality, consistency, and strength of our products. With almost 6 million square feet of growing space, we are committed to providing a consistent supply of softgels and oils. We guarantee our supply for medical customers and will give you a 10% discount on the equivalent Spectrum Cannabis Softgel or Oil product in the unlikely event your product is unavailable.*
Dedicated customer support and expert advice
Registration and ordering will be as easy as ever. Most importantly, the Spectrum Cannabis Customer Care team is dedicated to our medical patients and is available to you from 6 am to 10 pm EST, 7 days a week, beginning October 10. This includes access to expert advice and links to experienced medical cannabis educators.
By continuing as a customer with Spectrum Cannabis, you are ensuring continued access to high-quality, consistent products and the customer service you’ve come to rely on.
If you have any questions or concerns about how the legalization of recreational cannabis will affect you and access to your medicine, please contact us anytime — we are here to help.
*Customers must have registered or purchased the product in the past 60 days and both dosages of the Spectrum Cannabis Softgel product must be sold out to qualify.
Phone: 1 (855) 558-9333
Email: Care@SpectrumCannabis.com
S&P 500 futures go positive as rates dive on weak inflation data
Fred Imbert | Alexandra Gibbs
Published 4 Hours Ago Updated 42 Mins Ago
https://www.cnbc.com/2018/10/11/us-markets-focus-on-wall-street-rout-as-it-batters-global-markets.html
Markets may see some support today, But the Premarket on WEED this morning is Bid/Ask @ 60.60 @ 07:27MT after a close of 62.76 yesterday.
Securities watchdogs raise red flag over disclosure issues in pot industry?DAVID MILSTEAD?THE GLOBE AND MAIL?October 10 at 09:37 MT?
https://www.theglobeandmail.com/cannabis/article-securities-watchdogs-raise-red-flag-over-disclosure-issues-in-pot/
?Canada’s securities regulators say the cannabis industry has widespread disclosure problems that are getting in the way of investors’ understanding of how to best invest in pot stocks.?Regulators in four provinces reviewed 70 publicly-listed cannabis companies, known as “issuers” in securities-industry lingo, and revealed a laundry list of problems in a Canadian Securities Administrators staff notice Wednesday. ?Many had inadequate information in either their financial statements, or in the text of the management analysis that’s supposed to help explain the company’s financial performance. In the regulators’ views, nearly three-quarters of the companies with U.S. operations failed to provide enough information about the risks of operating in that country — and therefore failed to satisfy a February CSA staff notice on how to discuss U.S. operations.
And all of the licensed cannabis producers — 100 per cent, the CSA says — needed to improve disclosure around the “fair value” of their cannabis plants, a nagging accounting issue in Canada that’s been confusing investors for some time. ?The Cannabis companies were responsive to regulators’ concerns, the CSA said. “Where deficient disclosure was identified during our review, issuers either committed to prospective improvements or, when the deficiencies were pervasive, re-filed certain documents.”?The CSA is an umbrella group for Canada’s decentralized, provincial-based system of securities regulation, and acts to provide consistency across the country in the absence of a federal regulator. Provincial regulators in Alberta, British Columbia, Ontario and Québec conducted the reviews contained in Wednesday’s notice. ?The CSA’s review is part of a broad concern in Canada about cannabis accounting. As the provincial securities regulators have reviewed company filings and engaged with the companies, Canada’s Accounting Standards Board (AcSB) has conducted task force meetings to wrestle with the issues surrounding fair value.
At the same time, however, investors have bid up pot stocks in eager anticipation of what the future holds, driving shares to valuations that are disconnected with current earnings, no matter how they are reported. This leads many to question whether backward-looking financial statements are even relevant.?“We’re in a nascent industry, so the financial information is less relevant in the initial stages, because investors are more interested in what’s going to happen tomorrow,” says Anthony Scilipoti, CEO of Veritas Investment Research. He contrasts this with more established companies like Dollarama, which saw its shares plunge last quarter on a missed sales estimate. “This is a fully operating company that’s been going for a reasonable amount of time that you can reasonably predict what they’re going to deliver. If [cannabis company] Aphria misses, sure, it’s interesting, but it’s not as relevant, because that same day they can say they ‘we signed a deal with this company and we’re building out production’ and all things equal, the stock will rise.”?One problem with the historical numbers is that publicly traded cannabis companies in Canada use International Accounting Standards (IAS), which are global, directed out of the United Kingdom, and didn’t anticipate the issues in an emergent industry that wasn’t even legal a few years ago. The international standards are considered “principles based,” with less explicit guidance than in the U.S., or in the Canadian generally accepted accounting principles no longer used by public companies.?Those grey areas have created a lack of consistency in how companies report results, particularly in the application of “biological assets” standards that say companies must value their cannabis plants that are growing, but not yet ready to be sold.
Each quarter, cannabis companies assess the value of the plants in their inventory in order to place a number on the balance sheet. The change from one quarter to the next is recognized as a gain, and the income appears in the income statement, typically adding to profit. ?What’s confusing, however, is that the change in value of the unsold inventory is appearing near the top of the income statement, often in the cost of goods sold. In some cases, companies are reporting a gross profit — sales minus cost of sales — that’s far bigger than the revenue booked in the quarter.?Securities regulators found that 71 percent of the licensed producers didn’t separately disclose these fair value changes, failing to provide enough information to help investors sort this out. “It is critical for investors to be able to understand how much it costs a company to produce its product,” Wednesday’s staff notice reads. “Since fair value amounts in the [profit-and-loss statement] … are not costs that have been incurred related to cannabis sold, it is important for all fair value amounts to be separately disclosed, so that investors can understand a company’s cost of sales excluding any fair value amounts.”?Similarly, the international standards do not have explicit rules about what costs are attributable to the growth of biological assets, or whether they must be expensed immediately, appearing in the income statement, or can be “capitalized,” an accounting treatment where the costs are gradually recognized over time. The CSA says many Canadian cannabis companies haven’t been clear in their disclosures about what choices they’ve made in this regard, and could be misleading investors with their “gross profit” measures.?The CSA also said “all of the [licensed producers] we reviewed were providing deficient disclosure” in the area the processes and assumptions they were using to determine fair value.?Cannabis companies operating in the U.S. have their own disclosure challenges; since marijuana sales are allowed in many U.S. states, but still illegal at the federal level, there are a unique set of risks. And most of the companies fell short in warning their investors of them, even as regulators issued a February staff notice with guidance on the matter. Regulators’ review found 74 per cent of issuers with U.S. marijuana-related activities with problems. All are taking action to improve disclosure, with 17 per cent of the companies with U.S. operations re-filing their most recent management’s discussion and analysis form.?
Washington State Governor foresees ease of border regulations governing cannabis after midterms?IAN BAILEY?VANCOUVER?THE GLOBE AND MAIL?October 10 at 19:52 MT
https://www.theglobeandmail.com/canada/british-columbia/article-washington-state-governor-foresees-ease-of-border-regulations/
?Washington State’s Governor says he expects a shift in the balance of power in the U.S. capital after the midterm elections, and that will mean Canadians crossing the border from B.C. to his state will not have to worry as much if they want to bring legal marijuana with them.?But for now, Jay Inslee, a Democrat who has been touted as a prospective competitor for the 2020 Democratic presidential nomination, urged travellers not to bring cannabis across the border to avoid “unnecessary difficulty.”?“I believe this problem will get resolved over time. The rate of time it takes is largely dependent on the election results in the next three weeks of our federal government and in 2020,” Mr. Inslee said at a news conference after talks with B.C. Premier John Horgan.?“I would anticipate there are going to be significant changes in federal policy in this realm, relatively rapidly, and when that happens, this issue ought to be able to be resolved in one way or another.”
He did not elaborate. Midterm elections in November in the United States will test whether the Republican Party can keep control of the U.S. Senate and House of Representatives.
Washington State legalized cannabis in 2012, and the end to the prohibition of the substance in B.C. will come next week under Canadian federal law, but individuals crossing the border with pot may face sanctions for doing so.?“That seems odd,” Mr. Horgan told the news conference, held in conjunction with a conference on regional issues in Vancouver.?Mr. Horgan said he will raise the issue with Prime Minister Justin Trudeau and Mr. Inslee will deal with the U.S. government, which the Premier described as the “main obstacle” on the issue at this point. Mr. Inslee did not specifically respond to that point.?The Canadian government has warned that taking cannabis or a product containing cannabis across Canada’s international borders will still be illegal after Oct. 17 and can result in criminal penalties.
“That will be the case even if you are travelling to places that have legalized or decriminalized cannabis,” a Government of Canada website covering the legal reforms says.?“Although the possession of cannabis is legal in some U.S. states, it remains illegal under U.S. federal laws in any form and quantity, making it illegal to bring across the Canada-U.S. border.”?Asked if he had any advice for Canada on legalizing cannabis, Mr. Inslee said it was largely a success in Washington State because critics' fears on such issues as crime, significant use among youth and adverse health effects were not realized.?He said it is vital to have strong regulation of the industry, with a cautious approach to establishing outlets for sales. “We picked numbers we thought we could handle in a regulatory system and that has proven to be effective,” the Governor told reporters.
He also called for regulation of edibles “so consumers know what they are getting,” as well as the assessment of issues around use by children. “We’ve been fairly successful on that, but we’re continuing to refine the situation,” he said.?Mr. Horgan said British Columbia has been working on these issues.?“It has been a challenge,” the Premier said, adding the province tried to regulate the number of outlets, but dispensaries already exist, largely in urban centres. He said it will be necessary to relicense such operations. “That’s going to take some time.”?
Something in the air. Smells like some change could be coming regarding Cannabis Regulations South of 49. Perhaps Sooner than expected.
What might the Global Scenery look like say, 2023, give years out? Or 2028, Ten Years our?
Look at that. I’ve completely overlooked and taken for granted that in Just 7 short days... Canada will open a fully regulated Adult market...
7 days. Folks, we’ve been waiting for this for a long time.
U.S. clears up rules for cannabis industry workers crossing border ?DANIEL LEBLANC, MARK RENDELL?OTTAWA AND TORONTO?THE GLOBE AND MAIL?October 10 at 18:30 MT
https://www.theglobeandmail.com/cannabis/article-us-clears-up-rules-for-cannabis-industry-workers-crossing-border/
?The U.S. government has clarified that Canadians who are employed in the country’s legal cannabis industry are allowed to enter the United States for non-work purposes without negative repercussions at the border.?In a revised statement on its cannabis policy, U.S. Customs and Border Protection said: “A Canadian citizen working in or facilitating the proliferation of the legal marijuana industry in Canada, coming to the U.S. for reasons unrelated to the marijuana industry will generally be admissible to the U.S.”?The new wording eased concerns in sectors of the Canadian economy that are involved in the cannabis trade. Many people had feared that the U.S. government’s restrictive approach meant that if they tried to enter the United States, their names could end up on lists of individuals who are not allowed to cross the border.?Before the clarification was issued this week, the U.S. border agency said that employment in the cannabis industry could “affect admissibility to the U.S.” Senior officials at licensed producers, lawyers and industry consultants had cancelled or postponed trips for fear of being turned back and being flagged in border security records.?
People are now breathing a collective sigh of relief,” said Patricia Olasker, a partner at Davies Ward Phillips & Vineberg LLP. "I think a lot of trips are back on. I think people will fundamentally change their behaviour starting today.”
Allan Rewak of the Cannabis Council of Canada, which represents many major producers, added the move was a “positive sign of the continued normalization of the Canadian cannabis sector.”?Still, Ms. Olasker said people should be cautious if they plan to conduct business in the United States.?“There is still plenty of risk for lawyers and other advisers travelling to the U.S. to advise companies in the U.S. industry, but that’s a manageable risk," she said. "You can choose to do that or not, without fundamentally affecting your business, within your own borders.”?Meanwhile, organizations across Canada are announcing their workplace policies on the use of cannabis, adding to a patchwork of rules for people in so-called “security-sensitive positions.”?On Wednesday, Correctional Service Canada and the Canada Border Services Agency announced that their employees will have to refrain from consuming cannabis in the 24 hours before the start of their shifts.
The RCMP also confirmed that it will forbid gun-carrying officers, pilots and other officers involved in potentially dangerous activities from consuming cannabis in the 28 days leading to a shift.?The rules for police officers vary widely. In Calgary and Quebec City, officers are asked to abstain from cannabis consumption. Cities including Ottawa, Montreal and Vancouver are simply asking their officers to be “fit for duty.”?Jean-Sébastien Fallu, a researcher on drug addiction at the University of Montreal, said restrictive limits are not realistic and hard to apply.?“A police officer who smokes cannabis one evening will be fit for duty the following morning,” he said.?He added that there is no scientific basis to justify a 28-day ban, and that the RCMP policy “makes no sense.”?The RCMP justified its rule by pointing to questions in the scientific community on the long-term cognitive impact of cannabis. In addition, the RCMP pointed out that Mounties can be recalled for emergencies with little notice and need to be ready.
“Without established scientific information about cannabis impairment, the RCMP policy is taking a careful approach at this time, to ensure workplace and public safety is maintained at all times,” the force said in a statement on Wednesday.?The new policies will be hard to enforce, as the cannabis legislation did not change the rules governing workplace testing. Federal employees cannot be the subject of random drug tests.
Three important dates on the Riv Calendar for public shareholders imo, 0ct20, Nov20, Dec20. These are the 30-60-90 day lock-up period dates for the insider/private placement share holders. The PP was ~ $3.60 I believe, so if there will be any highlighted sell pressure ( other that that we've already seen, eek) it may be around those dates. I can wait.
In the meant time. Business as usual. The company is active in a bergeouning industry. It takes time for things to grow and mature. its hasn't been a month yet since the ipo. L day has yet to come and go. Ive noticed that many many many people are really looking to microwave the cake, instead of learning a recipe on how to bake. Not throwing any shade. just a general observation.
Rivers is still a buy for me. seeing it as definitely a long term play. Thinking it amplifies the vertical integration and diversification if investments in the industry. Every time the price drops, it seems more valuable. " Scared Money Don't Make Money" - RZA
So, I wonder if im getting this right? Are there some very loose lips over at APH? This is another major Multi national business deal said to be in the works that becomes public rumour before any actual deal is made, and clearly that can and perhaps has hurt the company before. I think the management needs to get a hold of this pronto. We can only imagine that Canopy has held an audience of this sort and hope that we only hear about it when and if an agreement is made. "Loose Lips Sink Ships " I think is the cliche.
Marlboro maker Altria in talks with pot grower Aphria
CHRISTINA PELLEGRINI AND MARINA STRAUSS
PUBLISHED OCTOBER 10, 2018
UPDATED 5 MINUTES AGO
FOR SUBSCRIBERS
https://www.theglobeandmail.com/cannabis/article-marlboro-maker-altria-in-talks-with-pot-grower-aphria
U.S. tobacco giant Altria Group Inc. is in talks to acquire an equity stake in Canadian cannabis grower Aphria Inc., multiple sources say.
Details of Altria’s proposed investment in Aphria are still being finalized, said the sources, who asked to remain unnamed because the talks are private. They said Altria has expressed an interest in acquiring a minority stake in the Leamington, Ont.-based grower with the intention of eventually holding a majority of the company’s shares.
The sources cautioned that it could take time for the two companies to strike a deal and that talks could still fall through.
With a market capitalization of US$119-billion, Virginia-based Altria makes tobacco, cigars and wine. It owns Philip Morris USA, the maker of Marlboro cigarettes, and has a significant stake in Anheuser-Busch InBev SA/NV, the world’s largest brewing company. Meanwhile, Aphria’s market value on Wednesday afternoon was $4.3-billion. Its stock price has doubled since mid-August to $17.37.
Altria executives have met with Aphria’s leadership team in Leamington on several occasions, the sources said. The most recent in-person discussions took place on Monday, with senior representatives making the trip from the U.S.
Officials with Altria and Aphria did not immediately return requests for comment on Wednesday.
Big consumer companies are increasingly looking to forge alliances with cannabis growers, which is helping fuel a frenzy and driving stock prices higher as Canada prepares for the legalization of recreational marijuana next Wednesday. Global alcohol giant Constellation Brands Inc. unveiled its plan to boost its stake in Canopy Growth Corp. to a majority position in August after having initially taken a 10-per-cent stake last fall. Molson Coors Brewing Co. has also moved into the cannabis space through a joint venture announced this summer with Quebec-based grower Hexo Corp.
Sources said Altria is pursuing a Constellation-style deal rather than a joint venture in the mould of Molson-Hexo.
Aphria is known for being a low-cost cultivator of marijuana, boasting a cash cost per gram of less than $1. Its production site has been a revolving door of late, with the company hosting tours for a number of beverage and consumer goods companies that want to learn about the cannabis business.
In its last fiscal year to Dec. 31, 2017, Altria recorded US$25.6-billion in net revenues, a slight decline from the last year. And US$22.6-billion of these sales are from smokeable products. It booked US$10-billion in net earnings.
Altria has been making a push to expand beyond conventional cigarettes by introducing products that are seen to be less harmful. Its portfolio of non-combustible products includes smokeless, oral and heated tobacco and e-vapor.
Altria’s stake in Belgium’s Anheuser-Busch InBev SA/NV, which makes popular brands such as Budweiser and Stella Artois, is about 10 per cent. In 2017, Altria received more than US$800-million in dividends – thanks to its interest in AB InBev.
It’s slightly Comical the way all the oracles come on here singing like birds to market their prophetic doom. I get it. You think it’s gonna go down and you’re here to let everyone know. But the fact is that one share of TWD.v even at the ipo of ~ $3.60 is Today valued at ~ $60. Fact.
1:1000 voting shares. That’s like an explosion proof Light Armoured Vehicle
NYSE: CGC) (TSX: WEED)
https://mobile.tmxmoney.com/quote/readnews/?id=5039948150155741&symbol=WEED
SMITHS FALLS, ON, Oct. 9, 2018 /CNW/ - Licence amendments for Canopy Growth Corporation's ("Canopy Growth" or the "Company") wholly-owned subsidiary, BC Tweed Joint Venture Inc. (BC Tweed) and its majority-owned joint venture, Les Serres Vert Cannabis Inc. (Vert Cannabis) have been issued by Health Canada, collectively representing approximately 1.1 million sq. ft. of new greenhouse growing space on Canada's largest cannabis platform.
The Company has, through its subsidiaries, established a 5.6 million sq. ft. platform, which is now over 75% licensed. This infrastructure will increase the quantity and diversity of products available to retail and wholesale customers in the recreational market and fortify the supply of cannabis products available to its medical customers.
"Our regulatory team and the teams in Delta and Mirabel have worked hard to bring these large-scale greenhouses online. Credit is due to these teams and the entire organization as we continue the push forward into a transformative year for our business," said Mark Zekulin, President and co-CEO, Canopy Growth.
These licence amendments are a major step forward but more capacity is required before the entire Canopy Growth platform is operational.
Here's to Future Growth (all across the country).
If I understand correctly, this is a “Firewall” type arrangement that allows Terra to liberally explore International opportunities (specifically US markets) and Canopy Rivers and Growth get a promissory note exercisable when those regulations change? Chicks leaving the nest? And there aren’t any additional listed liabilities or commitments from Rivers? TerrAscend is all grown up now going backpacking to see the world?
My biggest take on this is how much confidence there is in sentiments of US regulations changing in the near future from many parties. Maybe worth some extra DD.
Also, well played Canopy on the Export for research. In other words,
“ Good Morning shareholders. Yeah, we DID that.” Not will do, or going to. DONE.
Management
Meaning
Moat
Margins
From our Sister Corp. at rivers.
Canopy Rivers Announces Proposed Restructuring of Investment in TerrAscend
https://globenewswire.com/news-release/2018/10/09/1618314/0/en/Canopy-Rivers-Announces-Proposed-Restructuring-of-Investment-in-TerrAscend.html
Canopy Rivers Corporation
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES
TORONTO, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (the “Company”) (TSXV: RIV) is pleased to announce it has entered into an arrangement agreement (the “Arrangement Agreement”) through its wholly-owned subsidiary, Canopy Rivers Corporation (“Canopy Rivers”), with TerrAscend Corp. (“TerrAscend”) (CSE: TER) pursuant to which TerrAscend will restructure its share capital by way of a plan of arrangement under the Business Corporations Act (Ontario) (the “Arrangement”).
TerrAscend wishes to pursue strategic transactions in the cannabis sector internationally, including select opportunities in the United States. To accommodate TerrAscend’s strategic pursuits, while also maintaining strict compliance with industry regulations and the policies of the various securities exchanges, Canopy Rivers has agreed to restructure its investment and waive certain restrictive covenants that were granted by TerrAscend in connection with the original investment by Canopy Rivers, Canopy Growth Corporation (TSX: WEED, NYSE: CGC), JW Opportunities Master Fund Ltd., JW Partners LP, and Pharmaceutical Opportunities Fund LP.
“We are excited for our partners at TerrAscend to extend their investment and operating strategy into new global markets” said Bruce Linton, Chairman and Acting CEO of Canopy Rivers, and co-CEO of Canopy Growth Corporation. “As TerrAscend pursues international growth, beginning in what is anticipated to be the largest cannabis economy in the world, we believe their team is well-positioned to take advantage of opportunities in regulated jurisdictions, and we are confident in their ability to leverage their pharmaceutical resources and strategic relationship networks to identify and execute compelling transactions.”
Canopy Rivers currently owns 11,285,456 common shares (the “Common Shares”) in the capital of TerrAscend and common share purchase warrants (the “Warrants”) entitling Canopy Rivers to acquire 9,545,456 Common Shares at a price of $1.10 per Common Share.
Pursuant to the Arrangement, Canopy Rivers will exercise its Warrants for no cash consideration, resulting in the net issuance of 8,159,456 Common Shares based on the five day volume weighted average trading price of the Common Shares of TerrAscend on the Canadian Securities Exchange (the “CSE”) for the period ending October 5, 2018, the last trading day prior to the date of the Arrangement Agreement. All Common Shares held by Canopy Rivers will thereafter be exchanged pursuant to the Arrangement for new, conditionally exchangeable shares in the capital of TerrAscend (the “Exchangeable Shares”).
The Exchangeable Shares will become convertible into Common Shares following changes in U.S. federal laws regarding the cultivation, distribution or possession of marijuana, the compliance of TerrAscend with such laws and the approval of the various securities exchanges upon which the holder’s securities are listed. The Exchangeable Shares are not transferrable or monetizable until exchanged into Common Shares. In the interim, each holder of Exchangeable Shares will not be entitled to voting rights, dividends or other rights upon dissolution of TerrAscend.
“We are optimistic regarding the continued evolution of global cannabis regulations,” said Linton. “The restructuring of our investment in TerrAscend is intended to create long-term value for our shareholders as it positions the Company with optionality and conditional future exposure to a significant new market in a manner that is compliant with the current policies of the exchanges and regulations that govern our industry.”
The Company does not engage in any U.S. cannabis-related activities as defined in Canadian Securities Administrators Staff Notice 51-532. While the Company has an interest in TerrAscend, TerrAscend has not engaged in cannabis-related activities in the U.S. to date and will not do so until closing of the Arrangement. Cannabis remains a Schedule I drug under the United States Controlled Substances Act, making it illegal under federal law in the U.S. to cultivate, distribute or possess cannabis.
For TerrAscend, the Arrangement will require approval by 66 2/3 percent of the votes cast by its shareholders as well as a simple majority of disinterested shareholders voting at a special shareholder meeting. The Arrangement is also subject to all necessary regulatory approvals, including that of the CSE.
Canadian entrepreneurs cooking up edible pot products despite legalization delay
LAURA KANE
VANCOUVER
THE CANADIAN PRESS
PUBLISHED OCTOBER 8, 2018
UPDATED 3 HOURS AGO
https://www.theglobeandmail.com/cannabis/article-canadian-entrepreneurs-cooking-up-edible-pot-products-despite/
Yannick Craigwell doesn’t need to guess how large the Canadian appetite will be for edible pot once it’s legal. He already knows that it’s huge.
The Vancouver entrepreneur whips up marijuana-infused cookies, brownies and fudge that he sells online through his company Treats and Treats.
“Once it becomes legal, I think the only thing that’s going to change is you’re going to get the people who were raised to think ... ‘Weed is bad, it’s the devil’s lettuce,’ and they’re going to be open to trying,” he said.
“It’s not really anything to be afraid of, but we are stigmatized by the laws that we have on the books.”
Businesses across Canada are cooking up weed-laced goodies to prepare for their legalization next year. Companies are betting on a big market and hope to avoid some of the pitfalls seen in U.S. jurisdictions when edibles were legalized.
The only legal marijuana on Oct. 17 will be fresh or dried bud, oil, plants and seeds. The federal government has promised to develop regulations to support the sale of edibles and concentrates within a year and will launch consultations later in 2018 and 2019.
Canada’s cautious approach stands in contrast with Colorado, which had practically no restrictions when pot treats hit stores in 2014. The Rocky Mountain Poison and Drug Center received 87 marijuana exposure calls about children that year, nearly doubling the previous year’s total, although no children died.
The statistic grabbed headlines and pushed the state to introduce regulations in 2015. Edibles must now be contained in child-resistant packages, stamped with a universal symbol and divided into servings of 10 or fewer milligrams of THC, pot’s psychoactive ingredient. They also can’t be shaped like animals, fruit or people.
The dangers of edibles hit close to home last week when a young child on Vancouver Island ate pot-infused gummy bears. She was rushed to hospital in medical distress, RCMP said, but was expected to fully recover.
Health Canada is considering requiring a standardized cannabis symbol on labels and banning product forms, ingredients and flavouring agents that appeal to kids, said spokeswoman Tammy Jarbeau. Previously introduced regulations already require marijuana to be in child-resistant packaging.
The effects of edibles take longer to be experienced and last longer than those caused by smoking cannabis, she said, putting users at risk of overconsumption. And since edibles can look like normal food, there’s a risk that children and pets will accidentally eat them, she added.
“These two issues point to the need to control the amount of THC in edibles, as well as the need for measures to ensure that edibles are appropriately packaged and labelled,” she said.
It’s illegal for anyone other than a licensed producer to sell medical pot, but Mr. Craigwell said he operates in the “grey.” He requires online buyers to agree to terms and conditions that state they need cannabis for medical reasons and he also sells his edibles in dispensaries in Vancouver, where police have chosen not to crack down.
A standard dose of THC in Colorado is 10 mg, but Mr. Craigwell’s goodies range from 90 mg to 175 mg. He said he’s open to the government mandating a lower dose, but it should consider what customers want.
“All you’re doing is risking them going into the black market,” he said. “My business model won’t succeed if I don’t have customers.”
Mr. Craigwell advised first-timers to eat a small piece and wait to feel the effects.
“Start off with a quarter. Work your way up to a half, and then a whole,” he said.
Experts predict edibles will eat up a major chunk of the market once legal. Six out of 10 likely pot consumers will choose edibles, according to a Deloitte survey of 1,500 Canadians.
The format has less stigma than smoking, said Deloitte partner Jennifer Lee.
“We found that it was really a product category – baked goods, chocolate, candy, beverages, honey, (ice pops) — that is much more accessible,” she said.
Some companies are banking on alcohol-free cannabis beverages rising to the top of the pack.
The Coca-Cola Company has reportedly been in talks with Aurora Cannabis Inc. about beverages containing a non-psychoactive pot component. Molson Coors Canada teamed up with HEXO Corp. to sell marijuana-infused drinks, while Constellation Brands Inc., which makes Corona beer, invested $5-billion in Canopy Growth Corp.
Bruce Linton, Canopy’s chief executive, noted it’s already common to socialize over a beverage.
“At five o’clock, do you want to meet for a gummy bear or a glass of wine?” he asked.
Canopy has developed calorie-free drinks that deliver a high within seven to 12 minutes, rather than the usual delayed onset of an edible, Mr. Linton added.
Province Brands CEO Dooma Wendschuh said his company has also created a way to speed up the onset of a high from its beers brewed from the cannabis plant.
But Mr. Wendschuh said developing a product prior to its legalization has its challenges. He can’t currently taste-test the beers in this country.
“It’s been absurd,” he said. “In Canada, we can make this product ... but no one’s allowed to drink it.”
Canopy Growth Insiders Sell $135 Million of Stock
October 3, 2018 at 1:44 pm
https://www.newcannabisventures.com/canopy-growth-insiders-sell-135-million-of-stock/
Exclusive article by Alan Brochstein, CFA
With the stock near an all-time high, eleven Canopy Growth (TSX: WEED) (NYSE: CGC) insiders sold shares as the company’s FY19-Q2 was ending in September. The sales come on the heels of the acquisition of Canopy Health, and many followed options exercises. In total, insiders sold 2.08 million shares for proceeds of $135 million, per data posted to sedi.ca:
Director John Bell exercised options ranging from C$2.11 to C$30.145. CMO Dave Bigioni exercised options at C$8.91. Director Murray Goldman sold shares from Goldamp Holdings, which retains 1.5 million shares, and Goldman continues to hold a substantial number of shares indirectly in other entities. Co-CEO Bruce Linton made outright sales from HBAM Holdings, which holds over 2.25 million shares subsequently.
David Pryce exercised options at C$11.71. CFO Tim Saunders exercised options with strike prices ranging from C$1.92 to C9.88. Director Christopher Schnarr exercised options with strike prices ranging from C$3.85 to C$24.12. Chief Legal Officer Phillip Shaer exercised options ranging from C$2.68 to C$8.18. Director Peter Stringham exercised options at C$3.86. CIO Ru Wadasinghe exercised options ranging from C$3.86 to C$8.18. Co-CEO Mark Zekulin exercised options ranging from C$2.11 to C$9.88.
Co-CEO Bruce Linton has sold shares several times over the past few years, with the first sale made in June of 2016, when he sold 400,00 shares at prices ranging from C$2.68-2.78. In March of 2017, he sold an additional 350,000 shares at an average price of C$10.6427. In December of 2017, he sold 200,000 shares at an average price of C$20.1794.
CFO Saunders sold 116,667 shares in February 2017 at C$11.763 after exercising options at C$1.92, 50,000 shares in March 2017 at C$12.00 after exercising options at C2.95 and 149,999 shares at C$18.54 after exercising options at C$1.92-2.68.
The easy way to gather this is to publish the holdings of the officers here on the board. I’ve read it several times, but don’t recall the specific numbers off the top of my head. They are published somewhere, sedat I believe and or in the brokerage insider reports. I think if your going to make those claims, if they are true, then it’s best to present them as fact and less as opinions. Shareholders voted in favor of the corporation issuing “free” as you call them, shares to the officers, directors and employees as a portion of their compensation package, way back around $8cad when the corporation had much less market value, with the understanding that the compensation was for that specifically, to grow shareholders value. When Bruce sold a number of his shares at $8 Cad, the same sentiments were garnered as some treason. I’m not hereby defending or denouncing their decision to exercise their options, but for certain I’m not surprised. I’m also not able to predict wether the price they sold at will be the highest value ever. A very bold prediction, indeed. Anyway. I don’t think what your presenting is fact, as much as a partial. I guess , since I have decided to participate in this order with you, I’ll also do my part to present whatever fact I’m able to garner.
Options exercising. The “selling” was based on options issued for performance initiatives. Other than the exiting directors, the remaining officers hold significant positions in the corporation. All this information is publicly available and several articles have been written covering the subject.
Beautiful Document! I very much enjoyed reading this. Let’s recall, it’s was just a few (3) short years ago, we had to listen to our, then, minister of health Rona Ambrose proclaim to National Media that Cannabis had NO medicinal value. That really had me questioning hers and the Party’s motives. And yet here we are. My sniff test is telling me Oct 17 may be just like The Liberal Majority election victory and The Royal Assent of bill c-45, wildly anti-climatic. I’ve been checking on the OCS website, and with 10 days to go, it really doesn’t seem as if they are ready to go. No product availability catalogue and little to direct visitors of the webpage to the actual process of purchasing. We may get more favor from international media coverage and provinces like Manitoba that hopefully are ready to go with Bricks and Mortar outlets. For certain I will attempt to make a purchase on the OCS web page on day one to test the process. But with the general interest that I sense from the public about LDay, it just doesn’t seem to be gravitating towards the actual means of purchase .
Speculation: not to solicit, or imply. I had earlier presented my hypothesis regarding x biotech company(s) that may be of interest for either partnership or acquisition within Canopy Growth Corporation. A company I thought present excellent value was Delivera Corp. Tsxv: DVA. The company has engineered a proprietary transdermal cream technology to deliver pharmaceutical pain relief medicine. The biotechnology has proven successfully effective with common formulations such as Ibuprofen.
The potential market applications are apparent. A non ingested, topical, direct to affected area pain relief formulation. Patients with compromised digestion, and accute pain are able to target affected areas directly. There is a synergistic potential in medical and hospital settings, long term care and at home treatment. The technology compliments Canopy’s recent partnership announcement with Centric Health, the Clinical research and Trials of Canopy Health and the several other initiatives Canopy Growth is taking towards the medical applications of Cannabis. On top of that, in February 2016, DVA and Canopy had announced a formal agreement to market such types of products once they became available.
With that said, I present the most recent development from DVA:
( you will notice the familiar name to the Cannabis Sector of Canaccord Genuity Corp). Full Disclosure, I am currently Long DVA.
https://finance.yahoo.com/news/delivra-receiving-interest-expertise-technology-110000081.html?.tsrc=applewf
Delivra Receiving Interest for its Expertise and Technology for Use in the Cannabis and Pharma Industries
CNW Group
October 1, 2018, 5:00 AM MDT
TORONTO , Oct. 1, 2018 /CNW/ - Delivra Corp. (TSXV: DVA - "Delivra" or the "Company"), a scientific and biotechnology company, today announced that it has recently received inquiries from a number of interested parties in relation to the Company's proprietary transdermal delivery system platform, including its proprietary applications for the cannabis and pharma industries.
As a result of these inquiries, the Company has engaged Canaccord Genuity Corp. to act as exclusive financial advisor to identify, review, analyze and explore the range of strategic and other opportunities available to the Company within the cannabis and pharma industries. There can be no assurance that the Company will enter into any transaction, that there will be any change in the operation or ownership of the Company, or that the Company will take any other corporate action as a result of the review.
Delivra has not set a timetable for completion of the review process and it does not intend to disclose further developments with respect to the review unless and until required by law or until such disclosure is deemed appropriate by the Company. Delivra cautions that there are no guarantees that the process will result in a transaction of any kind, and if a transaction is undertaken, that there is no guarantee as to its terms or timing.
Delivra Receiving Interest for its Expertise and Technology for Use in the Cannabis and Pharma Industries
https://finance.yahoo.com/news/delivra-receiving-interest-expertise-technology-110000081.html?.tsrc=applewf
CNW Group
October 1, 2018, 5:00 AM MDT
TORONTO , Oct. 1, 2018 /CNW/ - Delivra Corp. (TSXV: DVA - "Delivra" or the "Company"), a scientific and biotechnology company, today announced that it has recently received inquiries from a number of interested parties in relation to the Company's proprietary transdermal delivery system platform, including its proprietary applications for the cannabis and pharma industries.
As a result of these inquiries, the Company has engaged Canaccord Genuity Corp. to act as exclusive financial advisor to identify, review, analyze and explore the range of strategic and other opportunities available to the Company within the cannabis and pharma industries. There can be no assurance that the Company will enter into any transaction, that there will be any change in the operation or ownership of the Company, or that the Company will take any other corporate action as a result of the review.
Delivra has not set a timetable for completion of the review process and it does not intend to disclose further developments with respect to the review unless and until required by law or until such disclosure is deemed appropriate by the Company. Delivra cautions that there are no guarantees that the process will result in a transaction of any kind, and if a transaction is undertaken, that there is no guarantee as to its terms or timing.
Hi Awesome. How’ve you been? It’s been a wilder ride on this board. 4 years buddy. Almost like we’re internet pen pals. I’m sure you followed up on your research to know those crops were intentionally destroyed because of bureaucratic red tape. And that seems to be affecting Businesses across the board. Break out the starch and ironing board, or simply take it to the dry cleaners. This suit will get tailored up. We’ve gone from reading your analysis that absolutely no one will want to purchase Lp products, to T-15 to L-day and your now explaining to us why there isn’t enough? Really? As I’m sure you can derive, this is a sort of community here on iHub for investors to discuss the in’s and outs of this business. There’s a lot to to be garnered. Knock on wood, I hope to fully pay off my mortgage this year or next through the amazing powerhouse of investment. I’m an 80’s kid. Not gloating at all. Im just want to highlight for you that not all angels are demons. There are good Businesses, run by some good people in the Cannabis Industry that I think would do very well with your financial and or moral support and perhaps you could benefit too. We’ve gone from dime bags and basement grow rooms, to GMP certified Can’t get enough make more rooms. I must admit, I admire your passion and commitment to the antics, but the track record of your analysis speaks for itself. You were right in regards to the ‘Home Grow’ rights and good for that, but you’ve been wrong about nearly everything else. You must be applying the scientific method, aiming to disprove the theory, and if it cannot be disproved, then it must be true. Well, It’s happening Bobby. Canada will make available to every unincarcerated adult citizen, the legal means to purchase and consume Cannabis on October 17, 2018. Meanwhile, elsewhere on this spaceship were all traveling, people are loosing their freedoms and rights for the same activities. Even with all the hiccups, can we at least celebrate that we are going in a better direction? This is a +1, is it not? Bobby?
Bobby?
Cannabis growers behind on shipments, provinces warn
MARK RENDELL AND CHRISTINA PELLEGRINI
PUBLISHED OCTOBER 4, 2018
UPDATED 3 HOURS AGO
Canada’s largest cannabis growers are behind on their first orders for recreational marijuana, a development that will leave consumers with less choice on Oct. 17, multiple provincial distributors and retailers are warning.
British Columbia says its four largest suppliers won’t meet shipping deadlines and are coming up short on their initial supply commitments. (The province declined to identify the growers by name). The B.C. Liquor Distribution Branch (BCLDB), the provincial distributor and retailer, initially planned to offer more than 150 strains of marijuana. But supply problems mean that it now expects to have only half that variety available in its online store and one government-run retail outlet in Kamloops later this month.
B.C. isn’t the only province facing shortages on the eve of legalization. Nova Scotia says there will be less inventory and variety than planned in its 12 stores. Quebec is also bracing for the possibility of lower supply for its dozen initial retail locations and online shop.
Lower than expected crop yields, a lack of packaging materials, issues with supply chains and product being sold elsewhere – such as to Canada’s medical market or exported to other countries – are all contributing to what could be a messy start to Canada’s much-anticipated recreational cannabis system. This dearth of cannabis has left provincial distributors scrambling to source more product and risks derailing the launch of Canada’s new legal program.
“The volume of product will be considerably lower than what licensed producers (LPs) originally committed to providing,” the B.C. Liquor Distribution Branch said this week in an e-mailed statement to The Globe and Mail. “B.C. isn’t alone in this situation; shortages are expected to impact all jurisdictions across Canada, as some LPs look to opportunities in overseas markets.”
Cannabis growers have told the Nova Scotia Liquor Corp. “to expect less than what we ordered,” said spokesperson Beverley Ware. “We anticipate there will be fewer SKUs and less inventory on hand,” she added.
In Quebec, meanwhile, the Société des alcools du Québec (SAQ) says it might be facing supply problems as the industry goes through inevitable growing pains over the coming months.
"There’s a lot of demand and not a lot of offerings, so we’re monitoring the situation closely,” said SAQ spokesperson Mathieu Gaudreault.
Still, the three provinces say they should have enough legal product available early on to satisfy consumer demand, even if selection is limited.
The Globe reached out to Ontario, Prince Edward Island and Manitoba, but had not received a reply at time of publication. A spokesperson for NB Liquor in New Brunswick said he couldn’t comment on LP supply issues. A Spokesperson for The Alberta Gaming, Liquor and Cannabis Commission was more upbeat in her assessment, saying Alberta does “not foresee any issues with our supply levels for retailers and the online platform.”
The problem would have been worse if more legal stores were opening this month. Ontario, for example, won’t have any storefronts open until next spring and will only be selling legal product online until then. As recently as August, the SAQ said it was planning to have 20 stores in October, eight more than it now expects to be open on Oct. 17.
No single issue is causing country-wide supply problems, says the BCLDB. It has been told by growers that crop yields have been lower than expected. Some producers are still waiting on sales licenses from Health Canada; others have partially licensed facilities, with only a handful of grow rooms producing product that can be legally sold.
There’s also “insufficient supply of packaging materials (including excise stamps) and processing delays due to manual packaging and labelling processes,” the BCLDB added in its e-mail. Excise stamps are stickers attached to products to show federal taxes have been paid, similar to what’s seen on cigarette cartons.
“At this point, it’s unknown how quickly LPs can resolve these issues,” the BCLDB said.
To make up for the shortage from its large suppliers, the BCLDB is reaching out to other LPs and doubling down on producers with available product.
Supply, however, is tight, with other provinces scouring for more cannabis.
“We’re being asked to supplement our orders. It’s bad news out there,” Eric Paul, chair of CannTrust Holdings Inc., said last week by phone. He added that CannTrust has already committed all of its available product. Logistical problems are making things worse.
“Part of the problem is getting those little excise stamps. We’re short of stickers and we can’t ship without them,” Mr. Paul added. A bottleneck is forming at the point where the adhesive is applied to the stamps, multiple sources say.
“That slows the industry down,” he said. “Everybody’s behind the eight ball.”
https://www.theglobeandmail.com/cannabis/article-pot-growers-behind-on-shipments-provinces-warn/
TrueGEN Selects Martello for SD-WAN Solution that Addresses the Security and Performance Limitations of MPLS Deployments
CNW Group
CNW GroupOctober 3, 2018, 7:00 AM MDT
Networking and security company's security-conscious MPLS customers appreciate additional encryption layer and flexible, stable connectivity.
https://finance.yahoo.com/news/truegen-selects-martello-sd-wan-130000625.html?.tsrc=applewf
OTTAWA , Oct. 3, 2018 /CNW/ - Martello Technologies Group Inc. ("Martello") (MTLO.V), a leading provider of network performance management solutions for real-time communications, announced today that TrueGEN, a networking and security company based in Belgium , has selected Martello for its SD-WAN deployments. Many of TrueGEN's customers are seeking a solution that addresses the security and performance limitations of MPLS, and the company chose Martello's SD-WAN technology to assist in these multi-site deployments where connectivity, uptime and VPN performance are important. A Martello Elite Partner, TrueGEN specializes in IT Network Security, and by using Martello's Elfiq solutions, its customers will be provided with an extra layer of encryption.
Ive done some reading into this. specifically, Office Mark Zekulin on Sept 27, 2018, excerzised 368 334 options between 2.11-9.88 and on the same day sold 93,161 between 64.30 and 64.90.
I read this information from www.InkResearch.com through my online broker.
I think its as it reads. the options that would have been distributed years ago(for compensation packages perhaps) with a 3 year period were exercised. -15% account balance. Respectively Chris Schnarr who currently sits on the board with 96.99% votes in favour, will be removed from the Board to make way for an STZ Board member, his position sold 343, 870 common share, and account balance is 0.
Any complimentary fact/error checking of this information is welcome. Thank you
Im don't know yet how to copy this page into the hub, I can see it on the insider report on my online broker
Or you can drive to your cellphone , laptop or desktop and place your order on the OCS webpage and have it delivered to your door in 1-2 days express,or 2-4 days standard delivery, the same way the acmpr has been functioning for 48 months, until April 1,2019 when outlet stores will be opening.
Canopy Co-CEO will be speaking at the CanEx in Jamaica presumably Today, or in the coming days.
https://canexjamaica.com/event-speakers/
Canopy Growth Provides Comments on Ontario Retail, BC Production, First Recreational Shipments
https://www.newswire.ca/news-releases/canopy-growth-provides-comments-on-ontario-retail-bc-production-first-recreational-shipments-694496671.html
SMITHS FALLS, ON, Sept. 27, 2018 /CNW/ - (Canopy Growth) (TSX: WEED) (NYSE: ) today responded to Ontario's retail rollout plan. The Company is looking forward to serving customers at retail locations at the site of its production facilities and especially looks forward to initiating the process of obtaining the necessary retail licences required to operate cannabis retail at its Smiths Falls headquarters where a merchandise store is already in place at a Tweed-branded visitor centre.
The Company looks forward to pursuing additional retail capabilities, taking advantage of the diversified arms of its business, including the newly acquired Tokyo Smoke platform, its multiple licensed production sites, and additional opportunities available through its affiliated investment arm, Canopy Rivers Inc. (TSXV: RIV). The Company believes that third party private retail represents a meaningful business opportunity compared to a provincially run retail system, and Canopy Growth's family of brands will feature prominently under any retail framework.
"The future of the Ontario cannabis market is bright," said Mark Zekulin, co-CEO and President, Canopy Growth. "As a cannabis business with multiple licenses and a variety of diverse subsidiaries, we feel we have a distinct advantage at this stage in the game. The Tweed and Tokyo Smoke retail experiences will offer unique and distinct experiences to appeal to anyone interested in cannabis. And we might even change a few minds."
Nationally, Canopy Growth will operate private retail in every province where it is permitted and will supply product to every province and territory with announced supply programs.
In depth licensing details will be made available through new provincial legislation. Once tabled, additional commentary will be possible.
In British Columbia, a one-time transfer of product has occurred, bringing product to Smiths Falls for processing. That product is proceeding through extraction and post-production for dried flower products at the Smiths Falls campus. Production licenses are in place at both sites, with more capacity possible once they are fully operational. Processing licences were delayed by infrastructure and regulatory approvals, which led to a number of plants needing to be destroyed. Management does not consider this event to represent a material impact on the company's balance sheet and fully anticipates being able to meet provincial supply agreements during the first year of recreational legalization.
Finally, the Company can confirm that it has completed a number of shipments to provinces in anticipation of the upcoming recreational cannabis regime. These shipments, the first of many, have been undertaken to stress-test the systems on both sides of the equation, and reflect a historic moment for the Company.
Here's to Future Growth.